Cross-Sector entity
Every one of those 2 sits in a single category, regulation. ALJ Derek C. Julius is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. We currently track 2 Cross-Sector stories that mention DEA, published between August 10, 2026 and August 14, 2026.
2 verified stories tracked
Last mentioned: Aug 14, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, regulation. ALJ Derek C. Julius is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. We currently track 2 Cross-Sector stories that mention DEA, published between August 10, 2026 and August 14, 2026. The tracked stories average 2 original sources each.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering DEA. Shared-story counts are live from our verified record — not editorial picks.
Post-Hearing Briefs Due
Parties submit final briefs to Administrative Law Judge Derek C. Julius, summarizing their arguments on the evidentiary record and legal standards. The recommendation on rescheduling is expected to follow shortly thereafter.
Syndicated coverage appears
California Telegraph and Hawaii Telegraph publish the MMJ statement.
MMJ International Holdings issues statement
MMJ says the Curaleaf file illustrates the federal scrutiny state-licensed marijuana operators could encounter when seeking DEA registration.
The Newsground publishes FBI Curaleaf investigation
Reporting based on FOIA records shows federal authorities examined Curaleaf financial activity for potential money-laundering and public-corruption violations; no criminal charges resulted.
Newly released FBI records on Curaleaf reveal the ownership and financing scrutiny state-licensed cannabis operators may face when entering the DEA registration system. For regulatory and white-collar counsel, the file signals expanded federal due diligence even when grand jury proceedings end without charges.
Source: californiatelegraph.com · hawaiitelegraph.com
ALJ Julius's upcoming recommendation in the DEA marijuana rescheduling hearing may challenge the government's novel approach of limiting Schedule III status to state-licensed medical programs, after DEA scientist testimony cast doubt on whether such programs satisfy the Controlled Substances Act's rigorous medical-use standard.
Source: nashvilleherald.com · pittsburghstar.com
